Tularik Inc. (TLRK) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (492)	7/16/2003 7:34:00 PM
From: Czechsinthemail	Read Replies (1) of 598

4:10PM Tularik misses by $0.08 (TLRK) 11.27 -0.33: Reports Q2 (Jun) loss of $0.53 per share, $0.08 worse than the Reuters Research consensus of ($0.45); revenues fell 20.5% year/year to $5.2 mln vs the $7.3 mln consensus. TLRK has traded down after hours. In addition to the earnings miss, TLRK seems to have a continuing cash crunch. They estimated their cash burn at about $90 million, including AMGN payments and presumably other financing programs they are working on. That will go through their $174.2 million in cash, cash equivalents and marketable securities, including $15.9 million from Cumbre, in under two years. Additional financing looks like a given, so the main question would be whether they pursue it fairly soon or wait and hope for further stock appreciation -- perhaps helped along by some news.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next